z-logo
open-access-imgOpen Access
Preoperative Risk Score for Early Mortality After Up‐Front Pancreatic Cancer Surgery: A Nationwide Cohort Study
Author(s) -
BerezaCarlson Paulina,
Nilsson Johan,
Andersson Bodil
Publication year - 2022
Publication title -
world journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.115
H-Index - 148
eISSN - 1432-2323
pISSN - 0364-2313
DOI - 10.1007/s00268-022-06678-8
Subject(s) - medicine , abdominal surgery , odds ratio , cardiothoracic surgery , vascular surgery , malignancy , cardiac surgery , diabetes mellitus , pancreatic cancer , surgery , risk factor , cancer , endocrinology
Background Pancreatic ductal adenocarcinoma is a highly fatal malignancy. The aim was to identify preoperative factors for early mortality in up‐front resectable patients following pancreatoduodenectomy (PD) and develop an early mortality risk score. Methods Patients registered in the Swedish National Registry for Pancreatic and Periampullary Cancer were included. Relevant preoperative factors ( n  = 21) were investigated. Early mortality was defined as death within 12 months after surgery. Based on the identified risk factor odds ratios (ORs), the Score Predicting Early Mortality (SPEM) was developed. Results In total, 2183 PDs were performed, and 926 patients met the study criteria. The mean age was 68 (SD ± 8.8) years, and 48% were female. A total of 233 (24%) patients died within 12 months. In the multivariable analyses, age > 75 years (OR 1.7; 95% CI 1.1–2.4; p  = 0.008), CRP ≥ 15 mg/L (OR 2.0; 95% CI 1.3–3.1; p  = 0.001), CA 19‐9 > 500 U/mL (OR 1.8; 95% CI 1.0–3.2; p  = 0.040), diabetes mellitus (OR 1.40; 95% CI 1.00–2.1; p  = 0.042), and active smoking (OR 1.47; 95%CI 1.00–2.00; p  = 0.050) were found to be independent risk factors for early mortality. Conclusion Five independent preoperative risk factors for early mortality following PD were identified and together formed SPEM. The score might be a useful tool in establishing individualized treatment plans.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here